CCEL

Healthcare Medical Care Facilities

Cryo-Cell International, Inc.

$3.71

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

29.91M

Avg Volume

22,920

EPS

-$0.31

52W High

$4.90

52W Low

$2.72

Div. Yield

0.0%

Valuation

Forward P/E

185.50

P/B Ratio

-1.68

P/S Ratio

0.96

EV/EBITDA

40.99

EV/Revenue

1.15

PEG Ratio

1.34

Margins

Gross Margin 63.9%

Operating Margin 15.4%

Net Margin (7.9%)

EBITDA Margin 2.8%

Growth & Returns

Revenue Growth (YoY)

(1.9%)

Earnings Growth (YoY)

72.1%

Earnings Growth (QoQ)

55.9%

Return on Assets

(0.1%)

Liquidity & Leverage

Current Ratio

0.71

Quick Ratio

0.63

Total Cash

3.16M

Total Debt

8.96M

About

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.